These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38386957)

  • 21. Cancer Care Professionals' Attitudes Toward Systematic Standardized Symptom Assessment and the Edmonton Symptom Assessment System After Large-Scale Population-Based Implementation in Ontario, Canada.
    Pereira JL; Chasen MR; Molloy S; Amernic H; Brundage MD; Green E; Kurkjian S; Krzyzanowska MK; Mahase W; Shabestari O; Tabing R; Klinger CA
    J Pain Symptom Manage; 2016 Apr; 51(4):662-672.e8. PubMed ID: 26743641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.
    Jarnagin JX; Saraf A; Baiev I; Chi G; van Seventer EE; Mojtahed A; Allen JN; Clark JW; Blaszkowsky L; Giantonio BJ; Weekes CD; Klempner SJ; Franses JW; Roeland EJ; Goyal L; Siravegna G; Horick N; Corcoran RB; Nipp RD; Parikh AR
    JAMA Netw Open; 2023 Nov; 6(11):e2343512. PubMed ID: 37976066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Abiraterone Acetate and Enzalutamide on Symptom Burden of Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer.
    Salem S; Komisarenko M; Timilshina N; Martin L; Grewal R; Alibhai S; Finelli A
    Clin Oncol (R Coll Radiol); 2017 Sep; 29(9):601-608. PubMed ID: 28395931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.
    Donlan J; Zeng C; Indriolo T; Li L; Zhu E; Zhou J; Pintro K; Horick N; Edelen M; Chung RT; El-Jawahri A; Ufere NN
    Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38497942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Japanese Version of the Edmonton Symptom Assessment System-Revised.
    Yokomichi N; Morita T; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Mori M; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2015 Nov; 50(5):718-23. PubMed ID: 26169339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric Properties of the Icelandic Version of the Revised Edmonton Symptom Assessment Scale.
    Gretarsdottir H; Fridriksdottir N; Gunnarsdottir S
    J Pain Symptom Manage; 2016 Jan; 51(1):133-7. PubMed ID: 26384555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of routine Edmonton symptom assessment system use on receiving palliative care services: results of a population-based retrospective-matched cohort analysis.
    Barbera L; Sutradhar R; Earle CC; Howell D; Mittman N; Li Q; Thiruchelvam D; Seow H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e144-e149. PubMed ID: 32943469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating symptom burden in kidney transplant recipients: validation of the revised Edmonton Symptom Assessment System for kidney transplant recipients - a single-center, cross-sectional study.
    Dano S; Pokarowski M; Liao B; Tang E; Ekundayo O; Li V; Edwards N; Ford H; Novak M; Mucsi I
    Transpl Int; 2020 Apr; 33(4):423-436. PubMed ID: 31919903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis.
    Hallet J; Sutradhar R; Isenberg-Grzeda E; Noel CW; Mahar AL; Vigod SN; Bolton J; Deleemans J; Chan WC; Coburn NG; Eskander A;
    JAMA Oncol; 2022 May; 8(5):e220203. PubMed ID: 35357419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between baseline symptom burden as assessed by patient-reported outcomes and overall survival of patients with metastatic cancer.
    Batra A; Yang L; Boyne DJ; Harper A; Cheung WY; Cuthbert CA
    Support Care Cancer; 2021 Mar; 29(3):1423-1431. PubMed ID: 32676854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer.
    Merchant SJ; Brogly SB; Booth CM; Goldie C; Nanji S; Patel SV; Lajkosz K; Baxter NN
    Ann Surg Oncol; 2019 Aug; 26(8):2336-2345. PubMed ID: 30969388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Chow S; Wan BA; Pidduck W; Zhang L; DeAngelis C; Chan S; Yee C; Drost L; Leung E; Sousa P; Lewis D; Lam H; Chow R; Lock M; Chow E
    Clin Breast Cancer; 2019 Dec; 19(6):405-410. PubMed ID: 31182402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Arabic Version of the Edmonton Symptom Assessment System.
    Shamieh O; Alarjeh G; Qadire MA; Amin Z; AlHawamdeh A; Al-Omari M; Mohtadi O; Illeyyan A; Ayaad O; Al-Ajarmeh S; Al-Tabba A; Ammar K; Al-Rimawi D; Abu-Nasser M; Abu Farsakh F; Hui D
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical and emotional symptom burden of patients with end-stage heart failure: what to measure, how and why.
    Opasich C; Gualco A; De Feo S; Barbieri M; Cioffi G; Giardini A; Majani G
    J Cardiovasc Med (Hagerstown); 2008 Nov; 9(11):1104-8. PubMed ID: 18852581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Edmonton Symptom Assessment Scale.
    Chang VT; Hwang SS; Feuerman M
    Cancer; 2000 May; 88(9):2164-71. PubMed ID: 10813730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison.
    Wong A; Tayjasanant S; Rodriguez-Nunez A; Park M; Liu D; Zapata KP; Allo J; Frisbee-Hume S; Williams J; Bruera E
    Oncologist; 2021 Feb; 26(2):165-171. PubMed ID: 33252169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related differences in symptom distress among patients with cancer.
    Hossain N; Prashad M; Huszti E; Li M; Alibhai S
    J Geriatr Oncol; 2023 Nov; 14(8):101601. PubMed ID: 37597295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal Clinically Important Difference in the Physical, Emotional, and Total Symptom Distress Scores of the Edmonton Symptom Assessment System.
    Hui D; Shamieh O; Paiva CE; Khamash O; Perez-Cruz PE; Kwon JH; Muckaden MA; Park M; Arthur J; Bruera E
    J Pain Symptom Manage; 2016 Feb; 51(2):262-9. PubMed ID: 26482223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the prevalence of dry mouth and other symptoms using two different versions of the Edmonton Symptom Assessment System on an inpatient palliative care unit.
    Monsen RE; Lerdal A; Nordgarden H; Gay CL; Herlofson BB
    BMC Palliat Care; 2024 Mar; 23(1):75. PubMed ID: 38493155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.
    Ripamonti CI; Bandieri E; Pessi MA; Maruelli A; Buonaccorso L; Miccinesi G
    Support Care Cancer; 2014 Mar; 22(3):783-93. PubMed ID: 24276952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.